BR0116553A - Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão - Google Patents

Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão

Info

Publication number
BR0116553A
BR0116553A BR0116553-4A BR0116553A BR0116553A BR 0116553 A BR0116553 A BR 0116553A BR 0116553 A BR0116553 A BR 0116553A BR 0116553 A BR0116553 A BR 0116553A
Authority
BR
Brazil
Prior art keywords
hypertension
angina
treating
pharmaceutical composition
composition
Prior art date
Application number
BR0116553-4A
Other languages
English (en)
Inventor
Jacobus Maria Lemmens
Theodorus Hendricus Ant Peters
Franciscus Bernardus Benneker
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0116553(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of BR0116553A publication Critical patent/BR0116553A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/90—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having more than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA PARA TRATAMENTO DE ANGINA OU HIPERTENSãO, PROCESSO, PROCESSO PARA TRATAMENTO OU PREVENçãO DE ANGINA OU HIPERTENSãO, COMPOSIçãO DE INGREDIENTES FARMACEUTICAMENTE ATIVOS, COMPOSIçãO FARMACêUTICA PARA TRATAMENTO OU PREVENçãO DE ANGINA OU HIPERTENSãO E PROCESSO PARA TRATAR OU PREVENIR ANGINA OU HIPERTENSãO". Um derivado de amlodipina com a fórmula aqui apresentada é útil, seja por si mesmo ou em combinação com amlodipina, como produto farmacêutico para tratamento de angina e hipertensão.
BR0116553-4A 2000-12-29 2001-08-15 Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão BR0116553A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25860200P 2000-12-29 2000-12-29
US80934901A 2001-03-16 2001-03-16
PCT/NL2001/000603 WO2002053540A1 (en) 2000-12-29 2001-08-15 Aspartate derivative of amlodipine as calcium channel antagonist
BE2001/0712A BE1014455A6 (nl) 2000-12-29 2001-11-05 Aspartaatderivaat van amlodipine.

Publications (1)

Publication Number Publication Date
BR0116553A true BR0116553A (pt) 2004-02-03

Family

ID=29740328

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116553-4A BR0116553A (pt) 2000-12-29 2001-08-15 Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão

Country Status (14)

Country Link
US (1) US6479525B2 (pt)
EP (1) EP1309558A1 (pt)
BE (1) BE1014455A6 (pt)
BR (1) BR0116553A (pt)
CA (2) CA2433191A1 (pt)
CR (1) CR7011A (pt)
DE (1) DE20116170U1 (pt)
GB (1) GB2372036B (pt)
GR (1) GR1004124B (pt)
HU (1) HUP0105456A3 (pt)
IE (1) IES20011105A2 (pt)
MX (1) MXPA03005886A (pt)
WO (1) WO2002053540A1 (pt)
ZA (1) ZA200110470B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001246883B2 (en) * 2000-04-11 2004-08-12 Sankyo Company, Limited Stabilized pharmaceutical compositions containing calcium channel blockers
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
MXPA03005882A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
EP1309554A1 (en) * 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Amide derivative of amlodipine
CN1272319C (zh) * 2000-12-29 2006-08-30 辉瑞有限公司 制备氨氯地平马来酸盐的工艺、所制得的氨氯地平马来酸盐、其药物组合物和用途
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
CA3038989A1 (en) 2016-10-07 2018-04-12 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
JP7456933B2 (ja) 2018-04-11 2024-03-27 シルバーゲイト ファーマシューティカルズ，インク． アムロジピン製剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (en) 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
CN1272319C (zh) * 2000-12-29 2006-08-30 辉瑞有限公司 制备氨氯地平马来酸盐的工艺、所制得的氨氯地平马来酸盐、其药物组合物和用途
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
WO2002054062A2 (en) 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
GB0114709D0 (en) 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate

Also Published As

Publication number Publication date
CA2366391C (en) 2005-10-18
GB2372036A (en) 2002-08-14
US20020128296A1 (en) 2002-09-12
HUP0105456A2 (en) 2002-10-28
MXPA03005886A (es) 2005-04-19
US6479525B2 (en) 2002-11-12
GB2372036B (en) 2004-05-19
EP1309558A1 (en) 2003-05-14
IES20011105A2 (en) 2002-12-30
HU0105456D0 (en) 2002-02-28
DE20116170U1 (de) 2002-04-04
CA2433191A1 (en) 2002-07-11
HUP0105456A3 (en) 2004-01-28
ZA200110470B (en) 2002-07-11
GR20010100602A (el) 2002-10-09
GR1004124B (el) 2003-01-24
CA2366391A1 (en) 2002-06-29
GB0131064D0 (en) 2002-02-13
CR7011A (es) 2004-03-10
BE1014455A6 (nl) 2003-10-07
WO2002053540A1 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
BR0100558A (pt) Composições e métodos para tratar a osteoporose
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
DE69823843D1 (de) Benzimidazolinone, benzoxazolinone, benzopiperazinone, indanone und deren derivate als faktor xa inhibitoren
BR0110420A (pt) Agonistas muscarìnicos
BR9811556A (pt) Terapia de combinação compreendendo atorvastatina e um agente anti-hipertensivo
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
BR9908275A (pt) Inibidores de enzimas fosfolipase
ATE346039T1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
GB0005251D0 (en) Therapeutic compounds
NO20025450D0 (no) Ny farmasöytisk sammensetning
EP1426375A3 (en) Analgesic spiroindole derivatives
ATE452640T1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
HK1068136A1 (en) Muscarinic antagonists
BR0213452A (pt) Derivados de piperazina com atividade antagonista receptora de ccr1
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
CO4910133A1 (es) Antagonistas de 5-h[1f]
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
BR9914901A (pt) Agonistas do receptor 5ht1 e metoclopramida para o tratamento de enxaqueca
BR9814923A (pt) Método para tratamento de doença de alzheimer
BRPI0313286A8 (pt) composição e atividade antiviral de derivados de piperazina azaindoloxoacético substituída
BR0315777A (pt) Uso de derivados de piperazina como antagonistas ccr1
BR0116553A (pt) Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão
BR9911060A (pt) Composições compreendendo mono- ou dinitrato orgânico para tratar impotência
WO2001001972A3 (en) SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
BR0113389A (pt) Compostos que inibem a atividade do fator xa

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]